Daniel Sauerstrom
Daniel Sauerstrom has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Allison Marie Lange
Principal Scientist, Analytical Services, Cambrex Corporation
1 shared publication - Jane Hall Diehl
Director, Global Medical Information, United Therapeutics Corporation, Research Triangle Park
1 shared publication - Margaret Rose Sketch
United Therapeutics Corporation, RTP, NC, United States
1 shared publication
Latest Publications
- Open Access
Short-term stability of diluted treprostinil sodium for subcutaneous administration
Background The Remunity Pump for Remodulin (treprostinil) Injection is an infusion system indicated for use with subcutaneous treprostinil. Objective The objective was to assess the stability of diluted treprostinil sodium stored in Remunity pump cassettes. Methods Treprostinil’s chemical and physical stability were assessed over a 76-hour period at 40 degrees Celsius and 75% relative humidity after dilution to 0.01 mg/mL in sterile water for injection and 0.9% sodium chloride. Analyses were conducted via visual inspection, pH measurement, and a stability-indicating high-performance liquid chromatographic assay. Results At all time points, the treprostinil samples were consistently clear, colorless, and free of visible particulate matter, with pH levels 6.0-7.0. All assays were within 90.0%-110.0% of the label claim, with minimal variation. Conclusions Treprostinil diluted to 0.01 mg/mL was stable in Remunity pump cassettes for up to 76 hours at elevated temperature and humidity. No notable changes from label claim concentration values were observed.
Open AccessShort-term stability of diluted treprostinil sodium for subcutaneous administration
Background The Remunity Pump for Remodulin (treprostinil) Injection is an infusion system indicated for use with subcutaneous treprostinil. Objective The objective was to assess the stability of diluted treprostinil sodium stored in Remunity pump cassettes. Methods Treprostinil’s chemical and physical stability were assessed over a 76-hour period at 40 degrees Celsius and 75% relative humidity after dilution to 0.01 mg/mL in sterile water for injection and 0.9% sodium chloride. Analyses were conducted via visual inspection, pH measurement, and a stability-indicating high-performance liquid chromatographic assay. Results At all time points, the treprostinil samples were consistently clear, colorless, and free of visible particulate matter, with pH levels 6.0-7.0. All assays were within 90.0%-110.0% of the label claim, with minimal variation. Conclusions Treprostinil diluted to 0.01 mg/mL was stable in Remunity pump cassettes for up to 76 hours at elevated temperature and humidity. No notable changes from label claim concentration values were observed.